• Breaking Down Barriers with GLP-1ᴿˣ: Noom’s New, Affordable Weight Loss Medication

  • Oct 11 2024
  • Length: 24 mins
  • Podcast

Breaking Down Barriers with GLP-1ᴿˣ: Noom’s New, Affordable Weight Loss Medication

  • Summary

  • Dr. Adonis Saremi, Noom's Chief Medical Officer, explains why Noom launched GLP-1ᴿˣ, an industry-first, affordable weight loss medication with a Taper-Off Guarantee.


    Dr. Adonis and Dayo Akinrinade, Founder and GM at Noom Vibe, discuss how the new class of GLP-1 medications (such as Ozempic and Wegovy) is revolutionizing weight loss. Dr. Adonis emphasizes the affordability and accessibility challenges patients face in obtaining GLP-1s, along with real-world issues like poor persistence and loss of lean muscle mass.


    This episode was recorded live on Noom Vibe, the free wellness community app from Noom. Noom Vibe makes building healthy habits fun and rewarding through a supportive community. Key features include an incentivized step and habit tracker, live conversations with coaches, and community connections. Noom Vibe is available now on the Apple App Store and Google Play.

    To learn more, visit NoomVibe.com.


    Curious about the basics of GLP-1 weight loss medications? Listen to this episode from the Noom Vibe podcast.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Breaking Down Barriers with GLP-1ᴿˣ: Noom’s New, Affordable Weight Loss Medication

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.